Tuesday, 4 June 2019

Sanofi loses German patent case against Amgen over cholesterol drug

Germany's highest civil court on Tuesday rejected French drugmaker Sanofi's bid to fend off a legal challenge by U.S. rival Amgen against Sanofi's cholesterol drug Praluent.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)